1.
Investigating the optimal size of anticancer nanomedicine
by Li Tang
Proceedings of the National Academy of Sciences, 28 October 2014, Vol.111(43), p.15344

2.
Nanomedicine-mediated cancer stem cell therapy
by Shen, Song
Biomaterials, January 2016, Vol.74, pp.1-18

3.
Cancer Immunotherapy and Nanomedicine
by Sheng, Wei-Yun
Pharmaceutical Research, 2011, Vol.28(2), pp.200-214

4.
Engineered nanomedicine for myeloma and bone microenvironment targeting
by Archana Swami
Proceedings of the National Academy of Sciences, 15 July 2014, Vol.111(28), p.10287

5.
Recent developments in nanomedicine for melanoma treatment.
by Tang, Jian-Qin
International journal of cancer, August 15, 2017, Vol.141(4), pp.646-653

6.
Immunomodulating Nanomedicine for Cancer Therapy.
by Liu, Zhigang
Nano letters, November 14, 2018, Vol.18(11), pp.6655-6659

7.
Microneedles: A New Frontier in Nanomedicine Delivery
by Larrañeta, Eneko
Pharmaceutical Research, 2016, Vol.33(5), pp.1055-1073

8.
Nanomedicine: Past, present and future – A global perspective
by Chang, Esther H
Biochemical and Biophysical Research Communications, 18 December 2015, Vol.468(3), pp.511-517

9.
Hierarchical Self‐Assembly for Nanomedicine
by Bishop, Kyle J. M.
Angewandte Chemie International Edition, 26 January 2016, Vol.55(5), pp.1598-1600

10.
Delta-like ligand 4-targeted nanomedicine for antiangiogenic cancer therapy
by Liu, Ya-Rong
Biomaterials, February 2015, Vol.42, pp.161-171

11.
Platelet microparticle-inspired clot-responsive nanomedicine for targeted fibrinolysis
by Pawlowski, Christa L
Biomaterials, June 2017, Vol.128, pp.94-108

12.
Two‐Dimensional Antimonene‐Based Photonic Nanomedicine for Cancer Theranostics
by Tao, Wei
Advanced Materials, September 2018, Vol.30(38), pp.n/a-n/a

13.
Dextran sulfate nanoparticles as a theranostic nanomedicine for rheumatoid arthritis
by Heo, Roun
Biomaterials, July 2017, Vol.131, pp.15-26

14.
NIR‐Responsive On‐Demand Release of CO from Metal Carbonyl‐Caged Graphene Oxide Nanomedicine
by He, Qianjun
Advanced Materials, November 2015, Vol.27(42), pp.6741-6746

15.
Dual Drug Backboned Shattering Polymeric Theranostic Nanomedicine for Synergistic Eradication of Patient‐Derived Lung Cancer
by Cong, Yuwei
Advanced Materials, March 2018, Vol.30(11), pp.n/a-n/a

16.
A superoxide dismutase/catalase mimetic nanomedicine for targeted therapy of inflammatory bowel disease
by Zhang, Qixiong
Biomaterials, October 2016, Vol.105, pp.206-221

17.
Nanomedicine's promising therapy: magnetic drug targeting
by Kempe, Henrik
Expert Review of Medical Devices, 01 May 2011, Vol.8(3), pp.291-294

18.
NIR-responsive and lectin-binding doxorubicin-loaded nanomedicine from Janus-type dendritic PAMAM amphiphiles.
by Sun, Lin
Biomacromolecules, November 12, 2012, Vol.13(11), pp.3581-3591

19.
Nanomedicine approaches in vascular disease: a review
by Gupta, Anirban Sen
Nanomedicine: Nanotechnology, Biology, and Medicine, December 2011, Vol.7(6), pp.763-779

20.
Nanomedicine highlights in atherosclerosis
by Karagkiozaki, Varvara
Journal of Nanoparticle Research, 2013, Vol.15(4), pp.1-17
